ASHLEY BRUESHABER: Open Payments
NPI 1104166800 · COMMERCE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 40 payments from 20 companies in 2025. Trend: 2023 $953 · 2024 $824 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| CSL Behring | 2 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $53 |
| Novo Nordisk Inc | 3 | $52 |
| Lundbeck LLC | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
Products named: REXULTI, OTEZLA, Hizentra, TRINTELLIX, MOUNJARO, FANAPT, BREZTRI, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
